GTRI

Gene Therapy Research Institution is a gene therapy developer dedicated to the research and development of neurodegenerative diseases. The company specializes in developing gene therapies for refractory diseases, primarily targeting Parkinson's disease, amyotrophic lateral sclerosis (ALS), and Alzheimer's disease, providing treatment options for patients suffering from these difficult-to-treat conditions.